Josefa García Barrado
Full Professor of Pharmacology and researcher in the Neuroendocrinology and Obesity group at the University of Salamanca
In my view, this article is highly innovative; it introduces a methodology for regulating blood glucose levels that differs significantly from existing approaches, as it does not rely on pharmacological treatments. It provides foundational evidence that controlled electrocatalysis leads to the formation of gluconate under specific conditions. From a technical standpoint, the methodology is compelling and highly applicable, featuring a well-designed implantable device with a closed-loop control system. However, given the novelty of this technology, it naturally raises reasonable questions regarding its practical application and potential side effects from a purely biological perspective.
The article builds upon existing biochemical knowledge concerning the products and outcomes of the electrochemical catalysis of glucose. Yet, it fails to address the potential changes that might arise from altering the chemical reaction environment—a critical consideration, given that the human body comprises numerous distinct microsystems. In this context, beyond gluconate, other products and byproducts could be generated—some of which, such as free fatty acids and ketone bodies, are mentioned in the article itself.
This work serves as a promising starting point for gaining a deeper understanding of how such devices might eventually become part of our therapeutic arsenal for conditions like diabetes and obesity.
Regarding the device itself, I see no inherent limitations; the approach is both novel and promising, demonstrating how technological advancement can significantly improve the quality of life for patients. Nevertheless, the potential outcomes of its use raise certain concerns that act as limitations. Broadly speaking, the article does not clarify whether the formation of other compounds resulting from electrocatalysis has been ruled out. Furthermore, it remains unclear whether variations in factors such as pH, exposure duration, or tissue location could alter the described conditions, potentially leading to harmful effects. Additionally, the study does not explore whether glucose byproducts—such as free fatty acids and ketone bodies—might have long-term metabolic consequences.